Both renal and ovarian clear cell carcinomas present common alterations of the DNA remodeling complex SWI–SNF, as well as PI3K-mTOR dysregulations, suggesting that drug development might be tumor agnostic for the clear cell histotype. Here, MTOR is linked to ovarian clear cell cancer.